Autres langues CARMAT

Actions

ALCAR

FR0010907956

Equipement, fournitures et distribution médicale

PEA

PEA/PME

Marché Fermé - Euronext Paris Autres places de cotation 17:55:00 10/07/2025			Varia. 5j.	Varia. 1 janv.
0,3390 ^EUR	-5,83 %		+7,11 %	-68,90 %

04/07	Paris : recule, la menace des tarifs incite à la prudence	CF
04/07	L'Europe finit dans le rouge, les pourparlers commerciaux dans la dernière ligne droite	RE

Autres langues

Carmat: cala il sipario	08/07
French and Benelux stocks-Factors to watch on Friday	04/07
CARMAT Announces the Initiation of a Call for Public Tenders (Buyers or Investors) as Part of the Receivership Procedure	03/07
CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social	02/07
CARMAT Announces Its Placement in Receivership Procedure	01/07
France's Carmat files for insolvency, shares suspended	30/06
France's Carmat files for insolvency, shares suspended	30/06
Artificial Heart Developer Carmat Files for Insolvency	30/06
CARMAT Announces Filing Today for Insolvency and Requesting Being Placed in Receivership	30/06
French and Benelux stocks-Factors to watch	23/06
Carmat Faces Insolvency Risk Amid Funding Challenges	22/06
French heart prosthesis firm Carmat at risk of insolvency by end-June	20/06
CARMAT : Inside Information / Other news releases	20/06
In a Context of Critical Financial Situation, CARMAT Launches a Donation Campaign Open to All to Contribute to Its Funding and Continuation of Its Activities	20/06
CARMAT Announces Being in a Critical Financial Situation and at Risk of Insolvency as of End-June 2025	20/06
CARMAT : Financial Statements for the year ended December 31, 2024	05/06
CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social	02/06
CARMAT Announces the First Commercial Implants of Its Aeson Artificial Heart Outside the European Union	02/06
Carmat: first two installations outside Europe	02/06
Carmat Announces First Commercial Implants Of Its Artificial Heart Outside The European Union	02/06
CARMAT Announces the First Commercial Implants of Its Aeson® Artificial Heart Outside the European Union	02/06
CARMAT Completes Enrolment in the EFICAS Clinical Study and Receives Approval from French Authorities for 21 Additional Aeson®? Implants, While Awaiting Potential Reimbursement of the Device in France	12/05
Carmat Completes Enrolment In Eficas Study, Approved For 21 More Aeson Implants	12/05
CARMAT Completes Enrolment in the EFICAS Clinical Study and Receives Approval From French Authorities for 21 Additional Aeson® Implants, While Awaiting Potential Reimbursement of the Device in France	12/05
CARMAT : Invest Securities raises target price	09/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Clap de fin pour Carmat

Le 08 juillet 2025 à 10:19